American Journal of Medical Genetics, Part A, 2025 (SCI-Expanded)
KBG syndrome is a rare autosomal dominant disorder caused by ANKRD11 variants, characterized by distinctive craniofacial features, short stature, skeletal anomalies, and neurodevelopmental impairment. Regional studies, particularly from underrepresented populations, are essential to broaden the clinical and molecular spectrum of the syndrome. We retrospectively analyzed the clinical, molecular, and anthropometric data of 23 Turkish individuals with molecularly confirmed KBG syndrome. Molecular analyses included whole exome sequencing, clinical exome sequencing, and targeted gene panels. Variants were classified according to ACMG guidelines, and phenotypic features were systematically assessed using standardized criteria. Eighteen distinct ANKRD11 pathogenic or likely pathogenic variants were identified, including eight novel variants, predominantly located in exon 9. Short stature (height SDS < –2) was documented in 30.4% of patients. Intellectual disability was observed in 82.6%, and behavioral anomalies in 52.2% of the cohort. Craniofacial dysmorphism, including long philtrum, triangular facial shape, and macrodontia, was prominent. No genotype–phenotype correlation could be established. This study expands the mutational landscape of ANKRD11 and underscores the clinical variability of KBG syndrome in a Turkish cohort. Our findings emphasize the importance of integrating molecular and detailed clinical evaluations for early diagnosis, especially in diverse populations with limited prior representation.